(WSPA)—Inflammatory bowel disease (IBD) targets your digestive system. As part of our “Ask the Expert” series, in partnership with Bon Secours St. Francis, 7NEWS spoke with an IBD director to learn ...

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, ...

LGBTQ+ individuals with inflammatory bowel disease experience multiple gaps and inequities in care when managing their ...

If you have Crohn’s disease, cooking your own meals can help you avoid foods that can trigger a flare. Get advice from cooking enthusiasts who live with the illness.

A hidden immune cascade linking the gut and bone marrow may explain how IBD turns inflammation into colon cancer.

Novel TL1A/IL23p19 bispecific antibody targets drivers of disease pathogenesis to overcome the efficacy ceiling in inflammatory bowel disease.

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Patients with inflammatory bowel disease (IBD) were 13% more ...

Appointments strengthen Palisade Bio's clinical strategy as PALI-2108 advances toward Phase 2 development in ulcerative colitis and fibrostenotic Crohn's disease, with a Phase 2 UC IND submission ...

Boehringer Ingelheim has penned a 1.05 billion euro ($1.26 billion) biobucks deal for Simcere’s preclinical inflammatory bowel disease (IBD) bispecific antibody. | Boehringer Ingelheim has penned a 1.

Boehringer Ingelheim has added another drug to its immunology pipeline, licensing an inflammatory bowel disease (IBD) ...

AstraZeneca made a big commitment to China as CEO Pascal Soriot joined British Prime Minister Keir Starmer on a trip to the ...